Living Cell Technologies Limited

LVCLY · OTC
Analyze with AI
6/30/2024
12/31/2023
6/30/2023
12/31/2022
Operating Activities
Net Income-$1,451-$801-$1,307
Dep. & Amort.$0$1$0
Deferred Tax$0$67$0
Stock-Based Comp.$744$0$1
Change in WC$0-$57$0
Other Non-Cash$442-$33$153
Operating Cash Flow-$1,009-$834-$1,152
Investing Activities
PP&E Inv.$0$0$0
Net Acquisitions$0$0$0
Inv. Purchases-$3,000$0$0
Inv. Sales/Matur.$2,023$0$0
Other Inv. Act.-$977$0$995
Investing Cash Flow-$977-$4,111$995
Financing Activities
Debt Repay.$0$0$0
Stock Issued$521$1,850$0
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$521$1,850$0
Financing Cash Flow$521$1,850$1,238
Forex Effect-$1$9-$1
Net Chg. in Cash-$489$1,025-$3,159
Supplemental Information
Beg. Cash$4,111$3,086$4,239
End Cash$3,622$4,111$1,079
Free Cash Flow-$1,009-$834-$1,152